New HIV prevention pill shows promise in emergency rooms
NCT ID NCT04233372
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 26 times
Summary
This study tested a once-daily pill called Delstrigo as a 28-day treatment to prevent HIV after a possible exposure. 399 adults who came to the emergency room after a potential HIV contact took the pill. The main goal was to see how many people completed the full 28-day course.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department and HIV & HCV Clinical Research Unit University Hospital Nantes
Nantes, France
-
Hospital Clínic de Barcelona
Barcelona, 08036, Spain
Conditions
Explore the condition pages connected to this study.